ArticleJournal of veterinary research2025
Evaluation of various filter paper and reagent systems for the preservation of Newcastle disease virus RNA samples.
Article in Journal of veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The transport of Newcastle disease virus (NDV) specimens, isolates or purified RNA is traditionally performed at ultra-low temperatures using dry ice to prevent degradation. However, this method is costly and requires specialised packaging and stringent shipping conditions. The aim of this study is to evaluate existing products' capacities to preserve NDV or its RNA under different conditions. Material and Methods: Flinders Technology Associates (FTA) cards, RNASound cards, and RNAstable tubes were tested for their ability to preserve NDV RNA at ambient temperatures. Two controls - free RNA and free virus - were included for comparison. Preservation was evaluated at various storage conditions (-80°C, -20°C, 4°C, 25°C and 56°C) and incubation times (1, 7, 14, 28 and 35 d) using a reverse-transcription PCR, Sanger sequencing and ratiometric fluorometry. Results: All preservation methods performed effectively at lower temperatures. The FTA cards maintained consistent RNA integrity with Δ threshold cycles < 2 except at 56°C on days 14-35. RNASound preserved RNA stably but was inconsistent on day 35 at 56°C. RNAstable was effective at intermediate times but had allowed complete degradation by day 35. Free RNA degraded rapidly after day 1, while free virus initially remained stable but deteriorated over time. Sanger sequencing confirmed high-quality recovery, except for recovery of free RNA, which lacked long-term stability. Conclusion: Despite challenges with prolonged storage and high temperatures, these methods demonstrated satisfactory performance. They offer viable alternatives to ultra-low temperature storage, enabling sample transport at ambient temperatures while preserving RNA integrity, and could be particularly useful in remote settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.